Table 3 Comparison of general information before and after matching between RAL and LSC subgroup of HL group.
Entire cohort | X2/t | P | PSM cohort | X2/t | P | |||
|---|---|---|---|---|---|---|---|---|
HL-LCS | HL-RAL | HL-LCS | HL-RAL | |||||
Age, years | 63.61 ± 6.64 | 64.44 ± 7.13 | -0.705 | 0.482 | 64.91 ± 6.78 | 63.34 ± 6.11 | 1.184 | 0.240 |
Sex, n (%) | 0.017 | 0.897 | 0.048 | 0.826 | ||||
Male | 25(33.33) | 22(34.38) | 16(34.04) | 15(31.91) | ||||
Female | 50(66.67) | 42(65.63) | 31(65.96) | 32(68.09) | ||||
BMI(kg/m2) | 25.67 ± 2.97 | 25.17 ± 3.46 | 0.906 | 0.366 | 25.74 ± 3.35 | 25.21 ± 3.41 | 0.763 | 0.447 |
Abdominal Surgery History(%) | 0.852 | 0.356 | 0.336 | 0.562 | ||||
No | 60(80.00) | 55(85.94) | 39(82.98) | 41(87.23) | ||||
Yes | 15(20.00) | 9(14.06) | 8(17.02) | 6(12.77) | ||||
Cardiopulmonary Diseases History(%) | 0.309 | 0.578 | 0.737 | 0.391 | ||||
No | 47(62.67) | 43(67.19) | 32(68.09) | 28(59.57) | ||||
Yes | 28(37.33) | 21(32.81) | 15(31.91) | 19(40.43) | ||||
Diabetes History(%) | 0.530 | 0.467 | 0.301 | 0.583 | ||||
No | 61(81.33) | 55(85.94) | 40(85.11) | 38(80.85) | ||||
Yes | 14(18.67) | 9(14.06) | 7(14.89) | 9(19.15) | ||||
Preoperative pyloric obstruction(%) | 0.343 | 0.558 | 0.079 | 0.778 | ||||
No | 63(84) | 56(87.5) | 39(82.98) | 40(85.11) | ||||
Yes | 12(16) | 8(12.5) | 8(17.02) | 7(14.89) | ||||
Preoperative smoking(%) | 1.216 | 0.270 | 0.072 | 0.789 | ||||
No | 64(85.33) | 50(78.13) | 39(82.98) | 38(80.85) | ||||
Yes | 11(14.67) | 14(21.88) | 8(17.02) | 9(19.15) | ||||
Preoperative malnutrition(%) | 12.081 | 0.001 | 0.000 | 1.000 | ||||
No | 55(73.33) | 61(95.31) | 43(91.49) | 44(93.62) | ||||
Yes | 20(26.67) | 3(4.69) | 4(8.51) | 3(6.38) | ||||
Preoperative neoadjuvant chemotherapy(%) | 0.046 | 0.829 | 0.000 | 1.000 | ||||
No | 72(96.00) | 60(93.75) | 46(97.87) | 45(95.74) | ||||
Yes | 3(4.00) | 4(6.25) | 1(2.13) | 2(4.26) | ||||
ASA classification, n (%) | 1.277 | 0.528 | 0.591 | 0.744 | ||||
I | 37(49.33) | 33(51.56) | 21(44.68) | 24(51.06) | ||||
II | 21(28.00) | 13(20.31) | 13(27.66) | 10(21.28) | ||||
III | 17(22.67) | 18(28.13) | 13(27.66) | 13(27.66) | ||||
Tumor TNM staging | 1.285 | 0.733 | 1.255 | 0.740 | ||||
I | 20(26.67) | 17(26.56) | 11(23.40) | 13(27.66) | ||||
II | 20(26.67) | 13(20.31) | 10(21.28) | 11(23.40) | ||||
III | 28(37.33) | 25(39.06) | 22(46.81) | 17(36.17) | ||||
IV | 7(9.33) | 9(14.06) | 4(8.51) | 6(12.77) | ||||
Tumor size (cm) | 3.33 ± 1.19 | 3.38 ± 1.20 | -0.259 | 0.796 | 3.17 ± 1.06 | 3.35 ± 1.25 | -0.725 | 0.470 |
Distance between tumor and anus (cm) | 8.33 ± 2.30 | 8.24 ± 2.37 | 0.221 | 0.825 | 8.49 ± 2.34 | 8.25 ± 2.59 | 0.477 | 0.634 |
Tumor location(%) | 1.516 | 0.468 | 0.531 | 0.767 | ||||
Lower (≤ 5 cm) | 18(24.00) | 10(15.63) | 8(17.02) | 6(12.77) | ||||
Middle (5.1–10 cm) | 29(38.67) | 28(43.75) | 19(40.43) | 22(46.81) | ||||
Upper (10.1–15 cm) | 28(37.33) | 26(40.63) | 20(42.55) | 19(40.43) | ||||
Degree of tumor differentiation(%) | 0.737 | 0.692 | 2.421 | 0.298 | ||||
low | 14(18.67) | 10(15.63) | 5(10.64) | 10(21.28) | ||||
middle | 39(52.00) | 31(48.44) | 28(59.57) | 22(46.81) | ||||
high | 22(29.33) | 23(35.94) | 14(29.79) | 15(31.91) | ||||